Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

Clinical trial NCT04374305 · RECRUITING

Trial details

NCT number: NCT04374305
Sponsor: Scott R. Plotkin, MD, PhD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neurofibromatosis Type 2 Vestibular Schwannoma Non-vestibular Schwannoma Meningioma Ependymoma

Start date: 2020-06-20
Primary completion: 2029-12-01
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.